Drugging the Plasmodium kinome: the benefits of academia–industry synergy
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (5) , 241-249
- https://doi.org/10.1016/j.tips.2008.02.005
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Plasmodium falciparum Regulatory Subunit of cAMP-Dependent PKA and Anion Channel ConductancePLoS Pathogens, 2008
- Disruption of the PfPK7Gene Impairs Schizogony and Sporogony in the Human Malaria ParasitePlasmodium falciparumEukaryotic Cell, 2008
- Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interactionBiochemical Journal, 2007
- The complement of protein kinases of the microsporidium Encephalitozoon cuniculi in relation to those of Saccharomyces cerevisiae and Schizosaccharomyces pombeBMC Genomics, 2007
- Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial MechanismAntimicrobial Agents and Chemotherapy, 2007
- Advancements in transfection technologies for PlasmodiumInternational Journal for Parasitology, 2007
- Plasmodium berghei calcium‐dependent protein kinase 3 is required for ookinete gliding motility and mosquito midgut invasionMolecular Microbiology, 2006
- Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicinesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000